Unlocking the potential

This study provides insights into weight gain patterns in patients on DTG-based regimens compared with those on non-DTG regimens. Younger individuals (15-24 years) exhibited higher odds of weight gain, suggesting a need for increased surveillance in this age group. These findings contribute to the understanding DTG's potential effects on weight gain, aiding clinical decision making. Further research is required to comprehensively understand the underlying mechanisms and long-term implications of weight gain in patients receiving DTG-based regimens

Adverse effect · Antiretroviral therapy · Body mass index · Body weight · Confidence interval · Dolutegravir · Human immunodeficiency virus (HIV · Interquartile range · Obesity · Overweight · Regimen · Tolerability · Underweight · Viral load · Weight change · Weight gain · Weight loss · Demography · HIV-related health complications and treatments · HIV/AIDS drug development and treatment · HIV/AIDS Research and Interventions · Medicine · Immunology · Internal Medicine